2011 Publications

Agnandji, ST; Lell, B; Soulanoudjingar, SS; Fernandes, JF; Abossolo, BP; Conzelmann, C; Methogo, BG; Doucka, Y;Flamen, A; Mordmüller, B; +132 more… (2011) First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. The New England journal of medicine, 365 (20). pp. 1863-75. ISSN 0028-4793 DOI: 10.1056/NEJMoa1102287

 

Alexander, N; Cundill, B; Sabatelli, L; Bethony, JM; Diemert, D; Hotez, P; Smith, PG; Rodrigues, LC; Brooker, S; (2011)Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths. Vaccine, 29 (20). pp. 3686-94. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.03.026

 

Ansong, D; Asante, KP; Vekemans, J; Owusu, SK; Owusu, R; Brobby, NA; Dosoo, D; Osei-Akoto, A; Osei-Kwakye, K; Asafo-Adjei, E; +19 more… (2011) T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children. PLoS One, 6 (4). e18891. ISSN 1932-6203 DOI:10.1371/journal.pone.0018891

 

Asante, KP; Abdulla, S; Agnandji, S; Lyimo, J; Vekemans, J; Soulanoudjingar, S; Owusu, R; Shomari, M; Leach, A; Jongert, E; +32 more… (2011) Safety and efficacy of the RTS,S/AS01(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. The Lancet infectious diseases. ISSN 1473-3099 DOI: 10.1016/S1473-3099(11)70100-1

 

Baguelin, M; Hoschler, K; Stanford, E; Waight, P; Hardelid, P; Andrews, N; Miller, E; (2011) Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation.PLoS One, 6 (2). ISSN 1932-6203 DOI: 10.1371/journal.pone.0017074

 

Barreto, ML; Pereira, SM; Pilger, D; Cruz, AA; Cunha, SS; Sant’Anna, C; Ichihara, MY; Genser, B; Rodrigues, LC; (2011)Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial. Vaccine, 29 (31). pp. 4875-4877. ISSN 0264-410X DOI:10.1016/j.vaccine.2011.05.023

 

Bejon, P; Cook, J; Bergmann-Leitner, E; Olotu, A; Lusingu, J; Mwacharo, J; Vekemans, J; Njuguna, P; Leach, A; Lievens, M; +11 more… (2011) Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01(E) on Blood Stage Immunity in Young Children. The Journal of infectious diseases, 204 (1). pp. 9-18. ISSN 0022-1899 DOI: 10.1093/infdis/jir222

 

Belard, S; Issifou, S; Hounkpatin, AB; Schaumburg, F; Ngoa, UA; Esen, M; Fendel, R; de Salazar, PM; Murbeth, RE;Milligan, P; +8 more… (2011) A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children. PLoS One, 6 (7). ISSN 1932-6203 DOI: 10.1371/journal.pone.0022525

 

Bregu, M; Draper, SJ; Hill, AVS; Greenwood, BM; Greenwood, B; Salisbury, D; (2011) Accelerating vaccine development and deployment: report of a Royal Society satellite meeting Vaccines and global health. Philosophical transactions of the Royal Society of London Series B, Biological sciences, 366 (1579). pp. 2841-2849. ISSN 0962-8436 DOI:10.1098/rstb.2011.0100

 

Chaiyakunapruk, N; Somkrua, R; Hutubessy, R; Henao, AM; Hombach, J; Melegaro, A; Edmunds, JW; Beutels, P; (2011)Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools. Bmc Medicine, 9. ISSN 1741-7015 DOI: 10.1186/1741-7015-9-53

 

Choi, YH; Jit, M; Gay, N; Andrews, N; Waight, PA; Melegaro, A; George, R; Miller, E; (2011) 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? PLoS One, 6 (10). e26190. ISSN 1932-6203 DOI: 10.1371/journal.pone.0026190

 

Christie, D; Viner, RM; Knox, K; Coen, PG; Wang, H; El Bashir, H; Legood, R; Patel, BC; Booy, R; (2011) Long-term outcomes of pneumococcal meningitis in childhood and adolescence. European journal of pediatrics. ISSN 0340-6199 DOI:10.1007/s00431-010-1390-5

 

Cooper, PJ; Chico, ME; Guadalupe, I; Sandoval, CA; Mitre, E; Platts-Mills, TAE; Barreto, ML; Rodrigues, LC; Strachan, DP;Griffin, GE; (2011) Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study. Bmc Infectious Diseases, 11. ISSN 1471-2334 DOI: 10.1186/1471-2334-11-184

 

Desai, S; Chapman, R; Jit, M; Nichols, T; Borrow, R; Wilding, M; Linford, C; Lowndes, CM; Nardone, A; Pebody, R; +1 more… (2011) Prevalence of human papillomavirus antibodies in males and females in England. Sexually transmitted diseases, 38 (7). pp. 622-9. ISSN 0148-5717 DOI: 10.1097/OLQ.0b013e31820bc880

Dockrell, HM; (2011) Another Step Down the Development Pipeline for the Novel Tuberculosis Vaccine MVA-85A. The Journal of infectious diseases, 203 (12). pp. 1708-9. ISSN 0022-1899 DOI: 10.1093/infdis/jir200

 

Easton, A; Haque, A; Chu, KR; Patel, N; Lukaszewski, RA; Krieg, AM; Titball, RW; Bancroft, GJ; (2011) Combining Vaccination and Postexposure CpG Therapy Provides Optimal Protection Against Lethal Sepsis in a Biodefense Model of Human Melioidosis. The Journal of infectious diseases, 204 (4). pp. 636-644. ISSN 0022-1899 DOI: 10.1093/infdis/jir301

 

Everett, DB; Mukaka, M; Denis, B; Gordon, SB; Carrol, ED; van Oosterhout, JJ; Molyneux, EM; Molyneux, M; French, N;Heyderman, RS; (2011) Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi. PLoS One, 6 (3). ISSN 1932-6203 DOI: 10.1371/journal.pone.0017765

 

Fine, P; Eames, K; Heymann, DL; (2011) “Herd immunity”: a rough guide. Clinical infectious diseases , 52 (7). pp. 911-6. ISSN 1058-4838 DOI: 10.1093/cid/cir007

 

Fowlkes, A; Witte, D; Beeler, J; Audet, S; Garcia, P; Curns, A; Yang, CF; Fudzulani, R; Broadhead, R; Bellini, WJ; +2 more…(2011) Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi. The Journal of infectious diseases, 204. S149-S157. ISSN 0022-1899 DOI: 10.1093/infdis/jir135

 

Garnett, GP; Cousens, S; Hallett, TB; Steketee, R; Walker, N; (2011) Mathematical models in the evaluation of health programmes. Lancet, 378 (9790). pp. 515-525. ISSN 0140-6736 DOI: 10.1016/S0140-6736(10)61505-X

 

Greenwood, B; Salisbury, D; Hill, AV; (2011) Vaccines and global health. Philosophical transactions of the Royal Society of London Series B, Biological sciences, 366 (1579). pp. 2733-42. ISSN 0962-8436 DOI: 10.1098/rstb.2011.0076

 

Greenwood, BM; Targett, GA; (2011) Malaria vaccines and the new malaria agenda. Clinical microbiology and infection , 17 (11). pp. 1600-7. ISSN 1198-743X DOI: 10.1111/j.1469-0691.2011.03612.x

 

Griffiths, UK; Clark, A; Shimanovich, V; Glinskaya, I; Tursunova, D; Kim, L; Mosina, L; Hajjeh, R; Edmond, K; (2011)Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan. PLoS One, 6 (6). e21472. ISSN 1932-6203 DOI: 10.1371/journal.pone.0021472

 

Griffiths, UK; Mounier-Jack, S; Oliveira-Cruz, V; Balabanova, D; Hanvoravongchai, P; Ongolo, P; (2011) How can measles eradication strengthen health care systems? The Journal of infectious diseases, 204 Suppl 1. S78-81. ISSN 0022-1899 DOI: 10.1093/infdis/jir090

 

Griffiths, UK; Santos, AC; Nundy, N; Jacoby, E; Matthias, D; (2011) Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: Comparative analysis from Brazil, India, and South Africa. Vaccine, 29 (5). pp. 969-75. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.11.038

 

Hanvoravongchai, P; Mounier-Jack, S; Oliveira Cruz, V; Balabanova, D; Biellik, R; Kitaw, Y; Koehlmoos, T; Loureiro, S;Molla, M; Nguyen, H; +7 more… (2011) Impact of measles elimination activities on immunization services and health systems: findings from six countries. The Journal of infectious diseases, 204 Suppl 1. S82-9. ISSN 0022-1899 DOI:10.1093/infdis/jir091

 

Hargreaves, JR; Greenwood, B; Clift, C; Goel, A; Roemer-Mahler, A; Smith, R; Heymann, DL; (2011) Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. Lancet, 378 (9806). pp. 1885-93. ISSN 0140-6736 DOI: 10.1016/S0140-6736(11)60687-9

 

Heymann, DL; Brilliant, L; (2011) Surveillance in eradication and elimination of infectious diseases: A progression through the years. Vaccine, 29 Suppl 4. D141-4. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.12.135

 

Horby, P; Pham, QT; Hens, N; Nguyen, TTY; le, QM; Dang, DT; Nguyen, ML; Nguyen, TH; Alexander, N; Edmunds, WJ;+2 more… (2011) Social Contact Patterns in Vietnam and Implications for the Control of Infectious Diseases. PLoS One, 6 (2). ISSN 1932-6203 DOI: 10.1371/journal.pone.0016965

 

Ibarz-Pavón, AB; Maclennan, J; Andrews, NJ; Gray, SJ; Urwin, R; Clarke, SC; Walker, AM; Evans, MR; Kroll, JS; Neal, KR;+12 more… (2011) Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. The Journal of infectious diseases, 204 (7). pp. 1046-53. ISSN 0022-1899 DOI:10.1093/infdis/jir466

 

Jauregui, B; Sinha, A; Clark, AD; Bolanos, BM; Resch, S; Toscano, CM; Matus, CR; Andrus, JK; (2011) Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO’s ProVac Initiative. Vaccine, 29 (5). pp. 1099-1106. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.11.075

 

Jit, M; Bilcke, J; Mangen, MJJ; Salo, H; Melliez, H; Edmunds, WJ; Yazdanpanah, Y; Beutels, P; (2011) Response to comment on article by Jit et al. “The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe”. Vaccine, 29 (21). pp. 3732-3733. ISSN 0264-410X DOI:10.1016/j.vaccine.2011.02.104

 

Jit, M; Chapman, R; Hughes, O; Choi, YH; (2011) Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model. BMJ (Clinical research ed), 343. d5775. ISSN 0959-8138 DOI:10.1136/bmj.d5775

 

Jit, M; Demarteau, N; Elbasha, E; Ginsberg, G; Kim, J; Praditsitthikorn, N; Sinanovic, E; Hutubessy, R; (2011) Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models. BMC Med, 9. p. 54. ISSN 1741-7015 DOI: 10.1186/1741-7015-9-54

 

Jit, M; Yuzbashyan, R; Sahakyan, G; Avagyan, T; Mosina, L; (2011) The cost-effectiveness of rotavirus vaccination in Armenia. Vaccine, 29 (48). pp. 9104-11. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.08.127

 

Konstantyner, T; Taddei, J; Rodrigues, LC; (2011) Risk factors for incomplete vaccination in children less than 18 months of age attending the nurseries of day-care centres in Sao Paulo, Brazil. Vaccine, 29 (50). pp. 9298-9302. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.10.020

 

Lalor, MK; Floyd, S; Gorak-Stolinska, P; Ben-Smith, A; Weir, RE; Smith, SG; Newport, MJ; Blitz, R; Mvula, H; Branson, K; +4 more… (2011) BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and Malawi. The Journal of infectious diseases, 204 (7). pp. 1075-85. ISSN 0022-1899 DOI: 10.1093/infdis/jir515

 

Lalor, MK; Floyd, S; Gorak-Stolinska, P; Weir, RE; Blitz, R; Branson, K; Fine, PE; Dockrell, HM; (2011) BCG Vaccination: A Role for Vitamin D? PLoS One, 6 (1). e16709. ISSN 1932-6203 DOI: 10.1371/journal.pone.0016709

 

Larson, HJ; Cooper, LZ; Eskola, J; Katz, SL; Ratzan, S; (2011) Addressing the vaccine confidence gap. Lancet. ISSN 0140-6736 DOI: 10.1016/S0140-6736(11)60678-8

 

Larson, HJ; Paterson, P; (2011) Eradicating polio: persisting challenges beyond endemic countries. Expert review of vaccines, 10 (12). pp. 1635-6. ISSN 1476-0584 DOI: 10.1586/erv.11.156

 

Levine, OS; Bloom, DE; Cherian, T; de Quadros, C; Sow, S; Wecker, J; Duclos, P; Greenwood, B; (2011) New Decade of Vaccines 4 The future of immunisation policy, implementation, and financing. Lancet, 378 (9789). pp. 439-448. ISSN 0140-6736 DOI: 10.1016/S0140-6736(11)60406-6

 

Licciardi, PV; Balloch, A; Russell, FM; Nahm, MH; Mulholland, K; Tang, MLK; (2011) Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function. Nature reviews Drug discovery, 10 (5). pp. 394-395. ISSN 1474-1776 DOI: 10.1038/nrd3012-c1

 

Matuschewski, K; Hafalla, JC; Borrmann, S; Friesen, J; (2011) Arrested Plasmodium liver stages as experimental anti-malaria vaccines. Human vaccines, 7. pp. 16-21. ISSN 1554-8600 DOI: 10.4161/hv.70.14557

 

Moxon, ER; Das, P; Greenwood, B; Heymann, DL; Horton, R; Levine, OS; Plotkin, S; Nossal, G; (2011) A call to action for the new decade of vaccines. Lancet, 378 (9788). pp. 298-302. ISSN 0140-6736 DOI: 10.1016/S0140-6736(11)60766-6

 

Neogi, SB; Hasan, H; Sheikh, K; Zodpey, S; (2011) Scope for rotavirus vaccination in India: revisiting the scientific evidence.Indian journal of pediatrics, 78 (10). pp. 1251-5. ISSN 0019-5456 DOI: 10.1007/s12098-011-0448-3

 

Olotu, A; Lusingu, J; Leach, A; Lievens, M; Vekemans, J; Msham, S; Lang, T; Gould, J; Dubois, MC; Jongert, E; +20 more…(2011) Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. The Lancet infectious diseases, 11 (2). pp. 102-109. ISSN 1473-3099 DOI: 10.1016/S1473-3099(10)70262-0

 

Patel, N; Conejero, L; De Reynal, M; Easton, A; Bancroft, GJ; Titball, RW; (2011) Development of vaccines against burkholderia pseudomallei. Front Microbiol, 2. p. 198. ISSN 1664-302X DOI: 10.3389/fmicb.2011.00198

 

Phillips, G; Tam, CC; Rodrigues, LC; Lopman, B; (2011) Risk factors for symptomatic and asymptomatic norovirus infection in the community. Epidemiology and infection, 139 (11). pp. 1676-86. ISSN 0950-2688 DOI:10.1017/S0950268810002839

 

Postma, MJ; Jit, M; Rozenbaum, MH; Standaert, B; Tu, HA; Hutubessy, RC; (2011) Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world. BMC Med, 9. p. 84. ISSN 1741-7015 DOI: 10.1186/1741-7015-9-84

 

Pérez de Diego, AC; Athmaram, TN; Stewart, M; Rodríguez-Sánchez, B; Sánchez-Vizcaíno, JM; Noad, R; Roy, P; (2011)Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep. PLoS One, 6 (10). e26666. ISSN 1932-6203 DOI: 10.1371/journal.pone.0026666

 

Roca, A; Hill, PC; Townend, J; Egere, U; Antonio, M; Bojang, A; Akisanya, A; Litchfield, T; Nsekpong, DE; Oluwalana, C; +3 more… (2011) Effects of Community-Wide Vaccination with PCV-7 on Pneumococcal Nasopharyngeal Carriage in The Gambia: A Cluster-Randomized Trial. PLoS medicine, 8 (10). e1001107. ISSN 1549-1277 DOI:10.1371/journal.pmed.1001107

 

Rodrigues, LC; Mangtani, P; Abubakar, I; (2011) How does the level of BCG vaccine protection against tuberculosis fall over time? BMJ, 343. d5974. ISSN 1468-5833 DOI: 10.1136/bmj.d5974

 

Russell, FM; Carapetis, JR; Burton, RL; Lin, J; Licciardi, PV; Balloch, A; Tikoduadua, L; Waqatakirewa, L; Cheung, YB; Tang, MLK; +2 more… (2011) Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age. Vaccine, 29 (3). pp. 535-544. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.10.046

 

Santos, AC; Roberts, JA; Cook, AJ; Simons, R; Sheehan, R; Lane, C; Adak, GK; Clifton-Hadley, FA; Rodrigues, LC; (2011) Salmonella Typhimurium and Salmonella Enteritidis in England: costs to patients, their families, and primary and community health services of the NHS. Epidemiology and infection, 139 (5). pp. 742-53. ISSN 0950-2688 DOI:10.1017/S0950268810001615

 

Scott, JA; Ojal, J; Ashton, L; Muhoro, A; Burbidge, P; Goldblatt, D; (2011) Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection.Clinical infectious diseases , 53 (7). pp. 663-70. ISSN 1058-4838 DOI: 10.1093/cid/cir444

 

Scott, P; Rutjes, AW; Bermetz, L; Robert, N; Scott, S; Lourenço, T; Egger, M; Low, N; (2011) Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis. Vaccine, 29 (52). pp. 9711-21. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.07.042 Full text not available from this repository.

Sirima, SB; Cousens, S; Druilhe, P; (2011) Protection against Malaria by MSP3 Candidate Vaccine. The New England journal of medicine, 365 (11). pp. 1062-1064. ISSN 0028-4793 DOI: 10.1056/NEJMc1100670

 

Tilson, L; Jit, M; Schmitz, S; Walsh, C; Garvey, P; McKeown, P; Barry, M; (2011) Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine, 29 (43). pp. 7463-73. ISSN 0264-410X DOI:10.1016/j.vaccine.2011.07.056

 

Uruena, A; Pippo, T; Betelu, MS; Virgilio, F; Giglio, N; Gentile, A; Jimenez, SG; Jauregui, B; Clark, AD; Diosque, M; +1 more… (2011) Cost-effectiveness analysis of the 10-and 13-valent pneumococcal conjugate vaccines in Argentina. Vaccine, 29 (31). pp. 4963-4972. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.04.111

 

Vekemans, J; Marsh, K; Greenwood, B; Leach, A; Kabore, W; Soulanoudjingar, S; Asante, KP; Ansong, D; Evans, J;Sacarlal, J; +9 more… (2011) Assessment of severe malaria in a multicenter, phase III, RTS,S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J, 10 (1). p. 221. ISSN 1475-2875 DOI: 10.1186/1475-2875-10-221

 

Weinberger, DM; Harboe, ZB; Flasche, S; Scott, JA; Lipsitch, M; (2011) Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. Epidemiology (Cambridge, Mass), 22 (2). pp. 199-207. ISSN 1044-3983 DOI: 10.1097/EDE.0b013e3182087634

 

van Hoek, AJ; Melegaro, A; Zagheni, E; Edmunds, WJ; Gay, N; (2011) Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine, 29 (13). pp. 2411-2420. ISSN 0264-410X DOI: 10.1016/j.vaccine.2011.01.037